Abstract. The radioligand binding assay technique is an extremely powerful tool for studying receptors. It allows an analysis of the interactions of hormones, neurotransmitters, and related drugs with their receptors. Most of the binding assays have widely been applied to crude membrane fractions prepared from many tissues, but in the conventional method, there are some limitations such as a yield loss of receptor-bearing membranes and a change in receptor environment upon homogenization and fractionation. Recently, in order to overcome these problems, a binding assay has been developed using intact tissue segments. This article presents a brief overview of the tissue segment binding assay that has been developed mainly in our department. Practical guidelines for setting up this new assay are presented, including segment preparation, choice of appropriate radioligand, optimizing assay conditions, and appropriate methods for data analysis. The unique advantages and disadvantages of the tissue segment binding method are discussed in comparison with those of conventional membrane binding methods. We suggest that the tissue segment binding method is a powerful tool for detecting the native properties of receptors occurring in tissues and cells without altering their environment.
Introduction
Every protein such as a receptor or enzyme is biosynthesized according to one corresponding gene. However, after expression, proteins may be frequently modified by many factors in native cells and tissues, so that these proteins no longer exhibit a single property (1 -3) . That is, even though the amino acid sequence is the same, interactions with polysaccharides, lipids, or associated proteins may result in distinct protein isoforms or conformations with different pharmacological and physiological properties. This diversity of protein function can be appreciated when the function of a particular protein in native tissues is compared with its function when expressed at high abundance in cultured cell environments that may not reflect the native environment. This diversity of function cannot be predicted by genomic or even proteomic analysis. Thus, as shown in Figure 1 , we propose a new research field, pharmacomics, in which all of the modified and unmodified proteins occurring in native tissues that govern a tissue's response to an agonist are designated as the receptor's 'pharmacome'. We suggest that the analysis of an individual receptor's pharmacome in the setting of intact tissues or cells is required to clarify the potential cell / tissue functions of an individual receptor. An important question to ask then is: How can one perform the analysis of a receptor's pharmacome? The tissue segment binding method is one approach for this kind of analysis.
Over the past two decades, the radioligand-binding method has been one of the most important techniques in studying the pharmacological characterization and biochemical identification of many types of receptors (4, 5) . This method was pioneered by Paton and Rang in 1965 (6) , who incubated intact strips of intestinal smooth muscle with 3 H-atropine, in order to study the ligand binding properties of acetylcholine receptors. However, the binding method was thereafter applied to crude particulates or membrane fractions prepared from tissue, because receptors can be detected at higher density in the fractionated membrane preparations and because centrifugation may remove any soluble interfering substances such as endogenous neurotransmitters and guanine nucleotides (5) . Up to the present time, the binding method using membrane fractions and / or homogenates has been widely employed for many purposes including the identification of receptors and the screening of drug candidates. However, since this conventional binding method needs a relatively large amount of target protein, there are limits to its application for small animals or small organs / tissues where the yield of receptor-bearing membranes is low after fractionation (7 -10). More importantly, there are often discrepancies between the binding affinity obtained using the conventional ligand binding method and the functional affinity obtained by a bioassay approach. This apparent discrepancy between the membrane binding and bioassay approaches suggests that tissue homogenization may change the receptor environment, resulting in a loss of associated components or a breaking down membrane structure (9, 10) . Therefore, a conventional binding method may not be appropriate for evaluating the multiple properties that a receptor may display in a variety of tissues (i.e., its 'pharmacome').
A quarter of a century after the first experiments by Paton and Rang (6), Morel and Godfraind (11) measured the direct binding of 3 H(+)PN 200-110 to intact rat brain microvessels in order to study the interaction of dihydropyridines with the calcium channels. Thereafter, three research groups have used this type of intact tissue segment binding method to quantify α 1 -adrenoceptors of blood vessels. These studies indicated that the tissue segment binding technique could be used not only for the study of ion channels but also for the study of receptors present in low abundance in small tissues (9, 12, 13) . More recently, the tissue segment binding method was able to document the presence of a putative α 1L -adrenoceptor that had previously been detected only in functional bioassay studies (14, 15) and had not been identified by a conventional membrane binding method. This result indicated that the tissue segment binding approach could have unique advantages for the Fig. 1 . Pharmacome and pharmacomics. Every protein is biosynthesized according to one corresponding gene. However, after biosynthesis many proteins occurring in native cells / tissues are modified by many factors, resulting in distinct isoforms or conformations with different pharmacological and physiological properties, even though the amino acid sequence is the same. This diversity, with a focus on pharmacological receptors, is shown by the arrows in this figure. All of the modified and unmodified receptor phenotypes occurring in native tissues are summarized as a receptor's 'pharmacome'. Thus, the analysis of a receptor's 'pharmacome' in keeping with the diverse native properties a receptor may exhibit, depending on the tissue in which it is expressed, becomes an important research field. For pharmacological receptors, one can use the term 'pharmacomics', in addition to genomics and proteomics. Different sensitivities of a receptor to a given drug, depending on the tissue in which the receptor resides can provide a powerful clue for the analysis of a receptor's 'pharmacome'. study of receptors with distinct properties in different tissues because both the functional and tissue segment binding methods use the same intact segments (10) . To date, the precise details of tissue segment binding method have not yet been discussed in depth. In this article, we describe the technical details of the tissue segment binding method which has been developed in our department and we discuss the relative advantages and challenges of the method.
Preparation of tissue segments
All tissues isolated from animals including humans can be used for the tissue segment binding method. Excised tissues are immediately immersed into an icecold, isotonic nutrient solution in order to maintain the native environment as well as possible. We use a modified Krebs-Henseleit solution that is commonly used in functional bioassay studies (10) . The composition is as follows: 120.7 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl 2 , 2.0 mM CaCl 2 , 1.2 mM NaH 2 PO 4 , 25.5 mM NaHCO 3 , and 11.5 mM glucose. The pH of the solution is maintained at 7.4 by gassing with 95% O 2 and 5% CO 2 . It is optimal to use tissues as soon as possible, but tissues may be stored in the KrebsHenseleit solution for up to 1 day at 4°C. Frozen tissues cannot be used for this method because the cell membrane must be maintained in its original / natural state. Under a stereoscopic microscope, surrounding unnecessary parts such as fat and connective tissues should be removed and then the target tissue is cut into small pieces, the size of which depends on the density of receptors examined. For example, blood vessels are opened lengthwise, and then the rectangular segments are prepared by sectioning the vessel. The length of vessel segments required for a study is dependent on their binding capacity: for example, 3 -4 mm for α 1 -adrenoceptors in rat tail artery and thoracic aorta (9) . The thickness of tissue segments must be also carefully considered because it takes some time for ligands to penetrate the tissue segments fully. For instance, in rat heart ventricle, the segments of approximately 2-mm block are prepared to detect β-adrenoceptors. In rat cerebral cortex, segments of approximately 2 mm in length, 1.5 mm in width, and 1 mm in thickness are used for the measurement of muscarinic acetylcholine receptors and α 1 -or β-adrenoceptors.
Since many segments must be prepared from one tissue, regional differences in binding capacity and binding characteristics must first be examined. In the rat tail artery, the abundance of α 1 -adrenoceptors is not significantly different between proximal and intermediate portions but is slightly reduced in the distal portion (9) . Therefore, a single rat tail artery preparation of approximately 10 cm from the root can be used for the isolation of 24 -30 segments. This number of segments is sufficient to perform one saturation or binding-competition experiment for α 1 -adrenoceptors. In the rat heart, there is no difference in the binding capacity of 3 H-CGP-12177 within the ventricle (right and left ventricular free walls, septum, apex), although regional differences in the abundance and proportions of β 1 -and β 2 -adrenoceptors can be observed between the atrium and ventricle (T. Horinouchi et al., in preparation).
Radioligands
For any given receptors there are now generally several commercially available radioligands. A most important question to ask for the successful conduct of a tissue segment binding assay is: Amongst the available receptor probes, which radioligand is most suitable? The utility of radioligands strongly depends on their physicochemical properties. In general, hydrophilic ligands are more useful to detect plasma membrane receptors, as compared with lipophilic ligands that may show a relatively high proportion of nonspecific binding. In this case, specific binding to receptors of radioligands should be distinguished from their intracellular / nonspecific accumulation. Some lipophilic ligands are able to detect not only plasma membrane-located receptors, but also intracellular receptors with a relatively low proportion of nonspeficic binding or accumulation. For α 1 -adrenoceptors, proportion of nonspecific binding. For nicotinic receptors, 3 H-epibatidine has been successfully used, but 3 Hnicotine can be accumulated intracellularly even at 4°C, masking the detection of receptor-specific binding.
All of the test radioligands must be diluted in the incubation buffers to be described (see next section). To minimize the amount of nonspecific radioligand binding to test tubes, glass but not plastic tubes must be used. Two radioisotopes ( 3 H and 125 I) are used to label radioligands. The advantages of tritiated over iodinated legands relate to the much longer half-life of 3 H and the unaltered chemical nature of the 3 H-labelled receptor probe that is biologically indistinguishable from the unlabelled compound. An advantage of the iodinated radioligands is their higher specific activity, which makes them particularly useful if the density of target receptor is low or if the amount of tissue is limited. The use of radioisotopes requires the usual care in terms of safety procedures to avoid exposure to the hydrocarboncontaining scintillation fluids or to radioactivity.
Assay conditions
Incubation buffer: The goal of using intact tissue in the tissue segment binding method is to avoid cell damage and to keep the receptor environment as close to that in tissues in vivo as possible. Therefore, isotonic nutrient solutions should be used. We use an incubation buffer (135.7 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl 2 , 2.0 mM CaCl 2 , 1.2 mM NaH 2 PO 4 , 10.5 mM NaHCO 3 , and 11.5 mM glucose, pH 7.4 in air), whose composition is essentially the same as the modified Krebs- Henseleit solution described above. However, since the incubation buffer can not be aerated during the incubation period, in contrast to the case of a functional bioassay gassed with 95% O 2 and 5% CO 2 , the NaHCO 3 concentration is reduced from 25.5 to 10.5 mM to adjust the pH to 7.4 under equilibration in room air, while the osmolarity is compensated by adding NaCl (10). This bicarbonate buffer solution is sufficient to keep the pH constant under the incubation conditions at low temperature. Some buffers such as HEPES (5 or 10 mM) may be added to fortify this bicarbonate buffer and to ensure that the pH is stabilized. Incubation volume: Glass tubes must be used for incubation and drug dilution because in contrast with glass tubes, plastic tubes rapidly absorb radioligands and competitive drugs, resulting in a rapid reduction in their concentrations during incubation and dilution (Fig. 2 , see below). We are using the following tubes: glass tubes (disposable culture tubes, Borosilicate Glass JR-2, code 9831-1207; Asahi Techno Glass, Chiba) and plastic tubes (polystyrene culture tube, code 530-B-1; Quality Scientific Plastics, Petaluma, CA, USA). The incubation volume varies depending on the binding capacity of the tissue segments. Usually we use a 1 ml incubation volume in saturation and binding competition experiments. If the total binding counts is over 10% of the amount of radioligand added into an incubation tube, either smaller tissue segments or a larger incubation volume (or both) must be considered in order to avoid a significant depletion (more than 10%) of the radioligand concentration during incubation. For example, in rat stomach, the density of muscarinic receptors is so high (approximately 1700 fmol / mg protein) that 2 ml of incubation buffer and small muscle segments (1 mm × 1 mm × 1 mm) are used ( Table 1) .
Incubation time and temperature: In tissue segment binding experiments, as for a conventional membrane binding procedure, the equilibrium binding conditions must be established for a meaningful analysis. Thus, the incubation time needs to be sufficient for the reaction to reach to equilibrium or steady state binding. For the tissue segment binding protocol, most of radioligands appear to take more than 10 h to reach equilibrium binding at 4°C (Fig. 2) . Some investigators may think Fig. 2 . Experimental protocol for the tissue segment binding method. A: Tissue segment is incubated at 4°C for more than several hours. B: Thereafter, the tissue segment is picked up, blotted, and then vortexed in a plastic tube containing a washing buffer at 4°C for approximately 1 min. C: The tissue segment is blotted again and then solubilized in 0.3 M NaOH solution at 37°C for 1 to 3 days. During solubilization, the test tube is strongly vortexed several times in order to cause rapid melting of the tissue segment. D: After tissue solubilization, the solution must be kept at 4°C before doing the measurements of radioactivity and protein content. Glass tubes are tightly sealed during shaking in A, solubulization in C, and storage in D. In the case of friable tissues such as brain segments, blotting on paper in B and C may be omitted and vortexing is done gently in B, although incomplete removal of unbound radioligand from the tissue segments must be carefully considered. Incubation and washing buffers are essentially the same. Thick horizontal arrows between A and B, B and C, or C and D represent that the tubes described in both panels are the same, respectively. that 37°C might be preferable, because that temperature is more physiological and because the resulting binding data might correspond better to the functional data measured at 37°C. However, even though binding equilibrium would be reached faster at 37°C, compared with 4°C, it can be pointed out that the intact tissue segments are incubated in an isotonic nutrient solution without bubbling air or oxygen. Thus, if equilibrated at 37°C for a tissue segment binding assay, tissue metabolism and anoxia would affect the binding of ligands. Furthermore, at 37°C, agonist treatment might further accelerate changes in the receptor state due to internalization and desensitization (3, 16) . In order to rule out these possibilities during incubation and to keep the original receptor environment, we have therefore selected to use low temperatures (generally 4°C). However, incubation conditions must be evaluated in depth, depending on the tissues, radioligands, and receptors being studied.
Washing: After incubation, tissue segments are washed at 4°C by a washing buffer that is the same as the incubation buffer used. As shown in Fig. 2 , a segment is picked up by forceps from an incubation tube and then blotted on paper. Then, the segment is quickly moved into a plastic tube containing ice-cold washing buffer (1 -2 ml) and vortexed at 4°C for approximately 1 min. By this procedure, most of the unbound radioligand is released from the segment into the washing buffer and is absorbed to the plastic tube, resulting in a rapid disappearance from the washing buffer. After washing, the segment is again blotted and moved into a glass tube for tissue solubilization. In the case of soft and friable tissues like brain, the blotting procedure may be omitted.
Tissue solubilization and protein assay: The washed segments are solubilized in alkaline solution to measure the bound radioactivity and protein content. It is important to note that under strongly alkaline conditions, proteins can be degraded into their amino acid constituents, so as to cause an artifactual decrease in the measured values for protein content. Figure 3 shows the stability of bovine serum albumin in different concentrations of NaOH solution stored at 37°C and 4°C, where bovine serum albumin was measured by the Bradford method (17) . An apparent loss of protein was observed over time at higher concentrations of NaOH at 37°C but not at 4°C. The time taken for tissue solubilization varies between the tissue types, the size of fragments, the temperatures, and the concentration of NaOH used. Tissues rich in collagen fibers take longer times to solubilize. We usually solubilize tissues over a 1 to 3 day time period at 37°C using 0.3 M NaOH. During this time period, the test tube is strongly vortexed several times. In general, solubilization is complete at 1 day for rat cerebral cortex but at 2 or 3 days for blood vessels. At 4°C, no apparent loss of protein was caused even in alkaline solutions (Fig. 3) . Therefore, after solubilization, the solution is stored at 4°C until the protein assay and radioactivity measurements are done. Half of the solubilized tissue solution is used to measure the radioactivity of bound radioligand and the remaining solution is used for protein assay. Whether alkaline solution affects either of these measurements must be also examined in preliminary experiments.
Data analysis
Since each tissue segment differs in size, each tissue segment has a different protein content. For normalization of the data, the radioactivity measured must be adjusted to the counts bound per 100 mg protein. Then, Fig. 3 . Effects of alkaline solution on bovine serum albumin and protein assay. Bovine serum albumin (8 mg/ml) was incubated in different NaOH solutions at either 37°C or 4°C and the protein contents were then measured after different incubation periods by the Bradford method (17), where 80 µl of different NaOH solutions was added into 1 ml (total volume) of assay medium.
binding data are analyzed using commercially available software (Graph Pad PRISM; GraphPad Software Inc., San Diego, CA, USA) (9, 10) . Representative data obtained from a saturation experiment with 3 H-QNB in rat cerebral cortex are shown in Table 2 and Fig. 4 . Binding abundance (B max ) estimated from tissue segment binding method represents the amount per mg total tissue protein; this value may be completely different from the amount bound per mg membrane protein obtained by a conventional binding method using crude membranes. Therefore, the receptor abundance must be compared using the same denominator; that is, per mg of total tissue protein. Table 1 shows binding data obtained in our department. 
Advantages and disadvantages of the tissue segment binding method
Compared with the conventional binding method using homogenates or microsomal membrane fractions, the most important advantage of the tissue segment binding method is that it avoids the low yield of receptor resulting from the homogenization and membrane fractionation procedure (Table 1) . For example, approximately 95% and 75% of α 1 -adrenoceptors disappear upon homogenization of rat tail artery and rabbit ear artery tissues, respectively (9, 10) . The yield of β-adrenoceptors in rat heart ventricle is also reduced by 70% upon homogenization. However, the yield of muscarinic receptors in rat cerebral cortex is not reduced by homogenization (Table 1) . Therefore, the abundance of many but not all receptors may be substantially underestimated using the conventional membrane binding method. The improved yield of receptor resulting from using the tissue segment binding method is of particular value for dealing with limited amount of tissues and / or small animals. A second significant merit of the tissue segment binding approach is the ability to detect receptors in a more physiological state, without changing the receptor environment. This approach may shed light on discrepancies observed between binding and functional studies. Recently, Hiraizumi-Hiraoka et al. (10) found that the putative α 1L -adrenoceptor can be clearly detected using the tissue segment binding method but disappears upon homogenization. The binding affinity for 3 H-QNB in rat cerebral cortex also differs approximately tenfold between measurements done using the tissue segment binding as opposed to binding measurements done using crude tissue homogenates (Table 1) . If hydrophilic and hydrophobic ligands are used that may or may not be able to cross the intact plasma membrane, then cell surface (detected by membrane impermeant ligands) as opposed to intracellular receptors (detected in addition to cell surface receptors by membrane permeable ligands) may be separately identified. A distinction between cell surface and intracellular receptors is not possible using a conventional binding procedure using either cell homogenates or isolated membranes. Because of these advantages, the tissue segment binding method can be a powerful tool for the analysis of receptor's native properties (i.e., its 'pharmacome') that can depend on interactions between the receptor and associated signaling components which may not be integral membrane proteins. Furthermore, the approach enables the analysis of the properties of receptors that may reside intracellularly where signaling may be possible and distinct from signaling generated at the plasma membrane. This distinction between the properties of a receptor situated in the membrane and the more extensive properties of a receptor conferred by all of its cytoplasmic-associated regulators can be referred to as the receptor's 'pharmacome', as outlined in Fig. 1 .
Unfortunately, the tissue segment binding method may not be applicable to all tissues. The nonspecific binding may mask specific binding in fibrous tissues, since connective tissues can bind many radioligands non-selectively. Secondly, tissue uniformity is required to avoid segment-to-segment differences. Binding to intact tissue represents the binding to many types of cells and connective tissues included in the segments. A different mixture of varieties of cells may lead to complex data. Third, since intact tissue is used for the segment binding approach, the regulatory changes in receptors that may occur during the course of incubation when the segments are incubated at relatively high temperature must be considered. Anoxia and agonist treatment may cause dramatic changes in the receptor environment and function during incubation at 37°C. In brief, the strengths of the tissue binding approach relate to the increased information that can be gained concerning a receptor's in vivo phenotype (i.e., its 'pharmacome') that can be different in different tissues, depending on the molecular interactions that the receptor may have with non-membrane cellular constituents. The weaknesses of the tissue binding method relate a) to the technical challenge that the procedure represents (cutting tissues, aliquotting, harvesting, washing, solubilization etc.), b) to the requirement for using fresh tissue that may degrade during an assay (as opposed to frozen stocks that can be used for membrane binding methods), and c) the complexity of binding that can occur in intact tissues due to multiple cell types and the presence of connective tissue that can increase nonspecific ligand binding. H-QNB using rat cerebral cortex segments. The data were obtained from Table 2 . Estimated KD and Bmax values are 920 pM and 1670 fmol /mg protein, respectively.
Conclusion
Receptors can no longer be viewed as static isolated entities, binding to their ligands in isolation from other cellular constituents found either in the membrane or the cytoplasm. Rather, in keeping with the mobile or floating receptor models proposed in the early 1970s (18) , the ligand binding properties of a receptor can be in a dynamic state, depending greatly on the interaction with other elements of the signal transduction pathway. The dynamic properties of a given receptor that enable it to adopt distinct, but different ligand binding phenotypes in distinct cellular environments comprise what can be termed a receptor's 'pharmacome', with each receptor displaying unique pharmacological and physiological properties in different intact tissues. These multiple binding phenotypes, comprising a receptor's 'pharmacome', may go undetected in routine ligand binding assays done after tissue homogenization. In this regard, the tissue segment binding method will be a powerful tool for the analysis of receptor's pharmacome that relates to its interactions with second messengers and associated proteins in the native tissue environment.
